← Eichor
Study identifier: NCT05231876 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

French Wilson Disease Registry

Condition: Wilson Disease  ·  Sponsor: Fondation Ophtalmologique Adolphe de Rothschild

PhaseN/A
Planned participants1000
Who can joinAll sexes, 0 Years to 99 Years
Healthy volunteersNo

About this study

This registry concerns adults and children with Wilson's disease. The collection of a large amount of data will allow a better understanding of the epidemiology of this rare disease, in particular the age of onset according to the hepatic or hepato-neurological forms, but also the geographical distribution of patients consulting in France. This database will also make it possible to know all the therapies prescribed to "Wilsonian" patients. The genetic study of these patients will make it possible to specify the various genetic mutations involved in Wilson's disease. The information (clinical, biological, radiological and genetic) relating to the disease will be entered by a doctor or a professional specialising in Wilson's disease.

This description comes directly from the study's public registry record.

Talk to the study team

Aurélia Poujois, MD, PhD  ·  (0)148036656  ·  apoujois@for.paris

Amélie Yavchitz, MD  ·  (0)148036454  ·  ayavchitz@for.paris

Always discuss trial participation with your own doctor first.

Locations (1)

Hôpital Fondation Adolphe de RothschildParis, Île-de-France Region, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05231876